| Dr Kathryn L Colman, MD | |
|
3000 N Halsted St, Suite 400, Chicago, IL 60657-5188 | |
| (773) 296-6550 | |
| (773) 296-5500 |
| Full Name | Dr Kathryn L Colman |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 19 Years |
| Location | 3000 N Halsted St, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508098476 | NPI | - | NPPES |
| 036135229 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MT186854 (Pennsylvania) | Secondary |
| 207Y00000X | Otolaryngology | 036135229 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Head And Neck Cosmetic Surgery Associates Llc | 2264476118 | 17 |
News Archive
Fast-track recruitment has begun for a trial to investigate the safety of a vaccine against H5N1 avian influenza, the National Institute of Allergy and Infectious Diseases (NIAID) announced today.
Cancer Research Technology - Cancer Research UK's development and commercialisation arm has teamed up with The University of Auckland to advance the discovery of new molecular targeted compounds for the treatment of leukaemia.
The September 11 terrorist attacks had a profound impact on this country's psyche.
An international research team co-led by the Ontario Cancer Institute has discovered a compound that kills specific lymphoma cells - a discovery that will accelerate developing targeted drugs to fight the most common form of non-Hodgkins lymphoma.
› Verified 2 days ago
| Entity Name | Head & Neck Cosmetic Surgery Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558330811 PECOS PAC ID: 2264476118 Enrollment ID: O20050613000607 |
News Archive
Fast-track recruitment has begun for a trial to investigate the safety of a vaccine against H5N1 avian influenza, the National Institute of Allergy and Infectious Diseases (NIAID) announced today.
Cancer Research Technology - Cancer Research UK's development and commercialisation arm has teamed up with The University of Auckland to advance the discovery of new molecular targeted compounds for the treatment of leukaemia.
The September 11 terrorist attacks had a profound impact on this country's psyche.
An international research team co-led by the Ontario Cancer Institute has discovered a compound that kills specific lymphoma cells - a discovery that will accelerate developing targeted drugs to fight the most common form of non-Hodgkins lymphoma.
› Verified 2 days ago
| Entity Name | Shriners Hospitals For Children |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871930693 PECOS PAC ID: 9133031933 Enrollment ID: O20131009001351 |
News Archive
Fast-track recruitment has begun for a trial to investigate the safety of a vaccine against H5N1 avian influenza, the National Institute of Allergy and Infectious Diseases (NIAID) announced today.
Cancer Research Technology - Cancer Research UK's development and commercialisation arm has teamed up with The University of Auckland to advance the discovery of new molecular targeted compounds for the treatment of leukaemia.
The September 11 terrorist attacks had a profound impact on this country's psyche.
An international research team co-led by the Ontario Cancer Institute has discovered a compound that kills specific lymphoma cells - a discovery that will accelerate developing targeted drugs to fight the most common form of non-Hodgkins lymphoma.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kathryn L Colman, MD Po Box 809094, Chicago, IL 60680-9094 Ph: (312) 236-3642 | Dr Kathryn L Colman, MD 3000 N Halsted St, Suite 400, Chicago, IL 60657-5188 Ph: (773) 296-6550 |
News Archive
Fast-track recruitment has begun for a trial to investigate the safety of a vaccine against H5N1 avian influenza, the National Institute of Allergy and Infectious Diseases (NIAID) announced today.
Cancer Research Technology - Cancer Research UK's development and commercialisation arm has teamed up with The University of Auckland to advance the discovery of new molecular targeted compounds for the treatment of leukaemia.
The September 11 terrorist attacks had a profound impact on this country's psyche.
An international research team co-led by the Ontario Cancer Institute has discovered a compound that kills specific lymphoma cells - a discovery that will accelerate developing targeted drugs to fight the most common form of non-Hodgkins lymphoma.
› Verified 2 days ago
Dr. Mausumi Natalie Syamal, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1611 W Harrison St, Chicago, IL 60612 Phone: 312-563-4100 | |
Laura Anna Petrauskas, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 5841 S Maryland Ave # Mc1035, Chicago, IL 60637 Phone: 630-254-6305 | |
Dr. Whitney E. Liddy, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 676 N Saint Clair St, Suite 15-200, Chicago, IL 60611 Phone: 312-695-4679 | |
Robert Kern, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611 Phone: 312-695-9797 | |
Dr. Elias M Michaelides, M. D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1611 W Harrison St Ste 550, Chicago, IL 60612 Phone: 312-942-6100 | |
Dr. Stephen Yeh Jr., M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 3860 West Ogden Avenue, Chicago, IL 60623 Phone: 872-588-3000 Fax: 847-998-0483 | |
Aimee Adair Kennedy, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Mc 1035, E-102, Chicago, IL 60637 Phone: 773-795-3158 |